Complete American Beacon Stephens Small Cap Growth Fund;R5 funds overview by Barron's. View the STSIX funds market news ...
Chicago Marathon announced that it has extended its partnership with Nike through 2036, continuing a relationship that began ...
A novel molecule plus rituximab was associated with higher response rates vs. rituximab alone, according to study data ...
UBS Global Biopharma Conference 2026 November 16, 2026 6:20 AM EST Hello. All right. Thank you, everyone, for coming today. My name is Dejia Zhang, and I'm on the UBS Investment Banking coverage team.
Everest Medicines raised HK$1.57B via a 2025 share placement, but its stock fell 63% by 2026 despite 142% revenue growth and ...
Travere Therapeutics has achieved two significant FDA approvals for FILSPARI, driving notable revenue growth. See why I rate ...
The RSUs vest over four years, with 25% of the shares vesting on each anniversary of the grant date, subject to the new ...
Detailed price information for Addus Homecare Corp (ADUS-Q) from The Globe and Mail including charting and trades.
DENVER — Sefaxersen, a novel messenger RNA-targeted therapy was linked to greater reduction in proteinuria and more likely resolution of baseline hematuria vs. placebo for patients with immunoglobulin ...
Travere Therapeutics (NASDAQ: TVTX) is attempting to change the pattern via which rare kidney diseases are treated. The ...
Shares of Travere Therapeutics took a hit Tuesday, but closed in the green, after fewer than expected patients started taking its drug.